Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls (Q43072099)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2010

Language	Label	Description	Also known as
English	Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls	scientific article published in August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

cerebrospinal fluid

0 references

1 reference

based on heuristic

inferred from title

Daniel Martins-de-Souza

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

object named as

Andrea Schmitt

4

0 references

object named as

Peter Falkai

7

0 references

Thomas Schneider-Axmann

6

object named as

Thomas Schneider-Axmann

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Thomas Wobrock

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Inga Zerr

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Joanna Gawinecka

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Christoph W Turck

8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

719-728

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Positive and negative symptoms in families with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Behavioural alterations in rats following neonatal hypoxia and effects of clozapine: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

CSF metabolic and proteomic profiles in patients prodromal for psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

A genome-wide association study in 574 schizophrenia trios using DNA pooling

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Apolipoprotein E genotype in Korean schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Prostaglandin D2 mediates neuronal protection via the DP1 receptor

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Longitudinal study of brain morphology in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Protective role of hematopoietic prostaglandin D synthase in transient focal cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

The untiring search for the most complete proteome representation: reviewing the methods

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

CNS synaptogenesis promoted by glia-derived cholesterol

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

TGFBR2 gene expression and genetic association with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Covert Transport Dysfunction in the Choroid Plexus as a Possible Cause of Schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Choroid plexus calcification as a possible marker of hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Altered thalamic membrane phospholipids in schizophrenia: a postmortem study

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Apolipoprotein E in schizophrenia: a French association study and meta-analysis.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Cytoprotective effect of acetyl-L-carnitine evidenced by analysis of gene expression in the rat brain.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Application of cDNA microarrays to examine gene expression differences in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Divergent effects of prostaglandin receptor signaling on neuronal survival

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Membrane pathology in schizophrenia: implication for arachidonic acid signaling

1 reference

https://api.crossref.org/works/10.3109%2F15622971003758748

21 January 2018

Identifiers

10.3109/15622971003758748

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43072099&oldid=2093240235"